BRPI0719345A2 - Di-hidroimidazóis substituídos e seu uso no tratamento de tumores. - Google Patents
Di-hidroimidazóis substituídos e seu uso no tratamento de tumores.Info
- Publication number
- BRPI0719345A2 BRPI0719345A2 BRPI0719345-9A2A BRPI0719345A BRPI0719345A2 BR PI0719345 A2 BRPI0719345 A2 BR PI0719345A2 BR PI0719345 A BRPI0719345 A BR PI0719345A BR PI0719345 A2 BRPI0719345 A2 BR PI0719345A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- hydroimidazols
- replaced
- treatment treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/40—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06124802 | 2006-11-27 | ||
| PCT/EP2007/062804 WO2008065068A2 (en) | 2006-11-27 | 2007-11-26 | Substituted dihydroimidazoles and their use in the treatment of tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0719345A2 true BRPI0719345A2 (pt) | 2014-03-18 |
Family
ID=38288488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0719345-9A2A BRPI0719345A2 (pt) | 2006-11-27 | 2007-11-26 | Di-hidroimidazóis substituídos e seu uso no tratamento de tumores. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100075966A1 (pt) |
| EP (1) | EP2097386A2 (pt) |
| JP (1) | JP2010510974A (pt) |
| KR (1) | KR20090083408A (pt) |
| CN (1) | CN101541759A (pt) |
| AU (1) | AU2007327621A1 (pt) |
| BR (1) | BRPI0719345A2 (pt) |
| CA (1) | CA2670105A1 (pt) |
| MX (1) | MX2009005622A (pt) |
| WO (1) | WO2008065068A2 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1945632B1 (en) | 2005-11-08 | 2013-09-18 | Vertex Pharmaceuticals Incorporated | Heterocyclic modulators of atp-binding cassette transporters |
| US8969386B2 (en) | 2007-05-09 | 2015-03-03 | Vertex Pharmaceuticals Incorporated | Modulators of CFTR |
| SI2225230T1 (sl) | 2007-12-07 | 2017-03-31 | Vertex Pharmaceuticals Incorporated | Trdne oblike 3-(6-(1-2,2-difluorobenzo(d)(1,3)dioxol-5-il)ciklopropan- karboksamido)-3-metilpiridin-2-il) benzojske kisline |
| EP2639224B1 (en) | 2007-12-07 | 2016-08-24 | Vertex Pharmaceuticals Incorporated | Process for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| NZ720282A (en) | 2008-02-28 | 2017-12-22 | Vertex Pharma | Heteroaryl derivatives as cftr modulators |
| EP2271621B1 (en) * | 2008-03-31 | 2013-11-20 | Vertex Pharmaceuticals Incorporated | Pyridyl derivatives as cftr modulators |
| JP5781928B2 (ja) * | 2008-07-16 | 2015-09-24 | ビトップ アーゲーｂｉｔｏｐ ＡＧ | 環状アミジンの合成 |
| HRP20211752T1 (hr) | 2010-04-07 | 2022-02-18 | Vertex Pharmaceuticals Incorporated | Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena |
| WO2012045018A1 (en) | 2010-09-30 | 2012-04-05 | St. Jude Children's Research Hospital | Aryl-substituted imidazoles |
| WO2013112804A1 (en) | 2012-01-25 | 2013-08-01 | Vertex Pharmaceuticals Incorporated | Formulations of 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| KR102196882B1 (ko) | 2012-12-20 | 2020-12-30 | 머크 샤프 앤드 돔 코포레이션 | Hdm2 억제제로서의 치환된 이미다조피리딘 |
| JP6963896B2 (ja) | 2013-11-12 | 2021-11-10 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | Ｃｆｔｒ媒介性疾患の処置のための医薬組成物を調製する方法 |
| PT3221692T (pt) | 2014-11-18 | 2021-09-10 | Vertex Pharma | Processo de realização de testagem de alta produtividade por cromatografia líquida de alta eficiência |
| WO2016112251A1 (en) * | 2015-01-09 | 2016-07-14 | Genentech, Inc. | 4,5-dihydroimidazole derivatives and their use as histone demethylase (kdm2b) inhibitors |
| CN110088081A (zh) * | 2017-06-16 | 2019-08-02 | 尤尼蒂生物技术公司 | 制备用于药物用途的对映纯顺式-咪唑啉化合物的合成方法 |
| WO2020263191A1 (en) * | 2019-06-27 | 2020-12-30 | Nanyang Technological University | Compounds having antimalarial activity |
| BR112022010924A2 (pt) | 2019-12-06 | 2022-09-06 | Vertex Pharma | Tetra-hidrofuranos substituídos como moduladores de canais de sódio |
| KR102622992B1 (ko) * | 2021-03-29 | 2024-01-10 | 주식회사 퓨전바이오텍 | 이미다졸린 유도체 및 이의 중간체 제조방법 |
| SMT202500481T1 (it) | 2021-06-04 | 2026-01-12 | Vertex Pharma | N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio |
| US11976047B1 (en) * | 2023-11-07 | 2024-05-07 | King Faisal University | 4,5-bis(4-bromo-phenyl)-1-hexyl-2-(2- methoxyphenyl)-1H-imidazole as an antimicrobial compound |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4814228B2 (ja) * | 2004-05-18 | 2011-11-16 | エフ．ホフマン−ラ ロシュ アーゲー | 新規ｃｉｓ−イミダゾリン |
-
2007
- 2007-11-26 JP JP2009537654A patent/JP2010510974A/ja active Pending
- 2007-11-26 KR KR1020097010729A patent/KR20090083408A/ko not_active Withdrawn
- 2007-11-26 US US12/516,414 patent/US20100075966A1/en not_active Abandoned
- 2007-11-26 CN CNA2007800437651A patent/CN101541759A/zh active Pending
- 2007-11-26 CA CA002670105A patent/CA2670105A1/en not_active Abandoned
- 2007-11-26 WO PCT/EP2007/062804 patent/WO2008065068A2/en not_active Ceased
- 2007-11-26 AU AU2007327621A patent/AU2007327621A1/en not_active Abandoned
- 2007-11-26 EP EP07822860A patent/EP2097386A2/en not_active Withdrawn
- 2007-11-26 BR BRPI0719345-9A2A patent/BRPI0719345A2/pt not_active Application Discontinuation
- 2007-11-26 MX MX2009005622A patent/MX2009005622A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090083408A (ko) | 2009-08-03 |
| CA2670105A1 (en) | 2008-06-05 |
| US20100075966A1 (en) | 2010-03-25 |
| JP2010510974A (ja) | 2010-04-08 |
| WO2008065068A2 (en) | 2008-06-05 |
| MX2009005622A (es) | 2009-06-12 |
| CN101541759A (zh) | 2009-09-23 |
| AU2007327621A1 (en) | 2008-06-05 |
| EP2097386A2 (en) | 2009-09-09 |
| WO2008065068A3 (en) | 2008-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0719345A2 (pt) | Di-hidroimidazóis substituídos e seu uso no tratamento de tumores. | |
| BRPI0718182A2 (pt) | Oligorribonucleotídeos e seus usos. | |
| BRPI0814267A2 (pt) | Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico. | |
| BRPI0808098A2 (pt) | 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas e seu uso | |
| BRPI0821276A2 (pt) | Produto, e, uso do produto | |
| BRPI0814963A2 (pt) | Pró-fármacos de dipeptóides e seu uso | |
| FI20045030L (fi) | Proomusovitelma, proomuyksikkö ja hinausyksikkö | |
| BRPI0813263A2 (pt) | Oxazolidinonas substituídas e seu uso | |
| EP2079489A4 (en) | ABSORBENT ARTICLE WITH ABSORPTION STRUCTURE | |
| SI2548577T1 (sl) | Človeška protitelesa proti il-23, sestavki, postopki in uporabe | |
| BRPI0720124A2 (pt) | Composições farmacêuticas e seus métodos de uso. | |
| BRPI0821027A2 (pt) | 4-(4-ciano-2-tioaril) dihidropirimidinonas e seu uso | |
| BRPI0718192A2 (pt) | Corantes dispersos, sua preparação e seu uso. | |
| BRPI0816372A2 (pt) | Ácidos 6-fenilnicotínicos substituídos e seu uso | |
| BRPI0817542A2 (pt) | NOVOS INIBIDORES DE sEH E SEU USO | |
| BRPI0817974A2 (pt) | Combinações de substâncias ativas com propriedades inseticidas e acaricidas. | |
| BRPI0813453A2 (pt) | 3-ciclopropil-4-(3-tiobenzoil)pirazol e seu uso como herbicida. | |
| BRPI0810461A2 (pt) | Combinação de drogas e seu uso no tratamento de perda muscular | |
| SI1858481T1 (sl) | Oftalmološki sestavki in njihova uporaba | |
| BRPI0921225A2 (pt) | caixinha porta-remédio e seu uso. | |
| BRPI0909096A2 (pt) | uso de conjugados de interleicna-1 no tratamento de diabetes | |
| BRPI0812340A2 (pt) | Macrociclos e seus usos | |
| BRPI0813937A2 (pt) | Derivado de 17beta-ciano-19-nor-andros-4-eno, seu uso e medicamentos contendo o derivado | |
| EP1889424A4 (en) | MESSAGE TRANSMISSION IN PAGE MODE | |
| FI20060864A0 (fi) | Integroitu systeemi, laite ja niiden käyttö |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |